MIF has been demonstrated to be significantly upregulated in various tumors, including colon cancer,66 prostate cancer,67 malignant melanoma,68 head and neck cancer,69 glioblastoma70 and breast cancer71 as well as lung cancer.72, 73, 74, 75, 76, 77. This evidence concerns the gene MIF and melanoma.